Learn More
BACKGROUND The combined efficacy analysis of the TEXT and SOFT trials showed a significant disease-free survival benefit with exemestane plus ovarian function suppression (OFS) compared with(More)
Locally advanced HER2-overexpressing breast cancer (BC) patients achieve a high rate of pathological complete responses (pCR) after neoadjuvant chemotherapy (NC). The apparently unaltered immune(More)
CONTEXT Intravenous fluid administration with peripherally inserted central venous catheters (PICCs) and midline catheters in palliative care. OBJECTIVES To evaluate distress and pain perceived by(More)